Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on September 3, 2026

Sep. 3, 2026

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire

Sep. 3, 2026

Ongwe Minerals Announces Voluntary Filing of Technical Report

Indeterminate GlobeNewswire

Sep. 3, 2026

Five Leading AI Search Optimization Service Providers in 2026: Shaping the Future of Intelligent Content Discovery

Indeterminate EIN Presswire

Sep. 3, 2026

Proofpoint Brings OpenAI GPT Cyber Models into Security Operations to Help Defenders Investigate Threats Faster

Indeterminate GlobeNewswire

Sep. 3, 2026

Sophos To Bring OpenAI GPT Cyber Models Into Managed Risk Offering, Helping Defenders Validate Exploit Paths

Indeterminate GlobeNewswire

Sep. 3, 2026

Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS

Indeterminate GlobeNewswire

Sep. 3, 2026

As AI reshapes business, Newsmatics teams up with Masaryk University to let students tackle real-world challenges

Indeterminate EIN Presswire

Sep. 3, 2026

Rogers and Quebecor Agree to New 12-Year Sublicensing Deal for National NHL Games in French

Indeterminate GlobeNewswire

Sep. 3, 2026

Rogers et Québecor concluent une nouvelle entente de sous-licence de 12 ans visant les droits nationaux de diffusion des matchs de la LNH en français

Indeterminate GlobeNewswire

Sep. 3, 2026

QCI Surpasses 100 Patent Assets in Casino Technology Innovation

Indeterminate GlobeNewswire

Sep. 3, 2026

DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre

Indeterminate GlobeNewswire

Sep. 3, 2026

DBV Technologies to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

New U.S. Treatment Recommendations Published for Severe Alopecia Areata in Adults

Indeterminate GlobeNewswire

Sep. 3, 2026

FingerMotion Announces Non-Binding Three-Party MOU with Lyken.AI and BlueFlare and Provides Update on Alberta Corridor Gas-Supply Discussions

Indeterminate GlobeNewswire

Sep. 3, 2026

Lianhe Sowell International Group Ltd. Announces Closing of an $11 Million Best-efforts Follow-on Public Offering

Indeterminate GlobeNewswire

Sep. 3, 2026

Vivani Medical Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism

Indeterminate GlobeNewswire

Sep. 3, 2026

L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.

Indeterminate GlobeNewswire

Sep. 3, 2026

LB Pharmaceuticals to Participate in Upcoming September Investor Events

Indeterminate GlobeNewswire